Feng, Yan <br/><br/>
PAX2 promotes epithelial ovarian cancer progression involving fatty acid metabolic reprogramming.  [electronic resource] 

 -  International journal of oncology  03 2020 
 - 697-708 p.  digital 
<br/><br/> Publication Type: Journal Article 
<br/><br/><label>ISSN: </label>1791-2423 
<br/><br/><label>Standard No.: </label>10.3892/ijo.2020.4958  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Animals<br/>Carcinoma, Ovarian Epithelial--genetics<br/>Cell Line<br/>Cell Proliferation<br/>Cell Transformation, Neoplastic<br/>Disease Progression<br/>Fatty Acids--metabolism<br/>Female<br/>Humans<br/>Mice<br/>Mice, SCID<br/>Mitochondria--metabolism<br/>Ovarian Neoplasms--genetics<br/>Oxidative Phosphorylation<br/>PAX2 Transcription Factor--genetics<br/>Prognosis<br/>Progression-Free Survival